Researchers at Trinity College Dublin will head to Latin America to investigate whether the probability of developing amyotrophic lateral sclerosis (ALS) is reduced in people with mixed ancestry. This new project will examine the hypothesis that mixed ancestral backgrounds might protect a person from developing ALS. Researchers will set up new…
Researchers report that evaluating a person’s control of tongue movement during speech can help to diagnose bulbar disease, especially in its early stages, in patients with amyotrophic lateral sclerosis (ALS). ALS affects motor neurons in the brain, brainstem, and spinal cord. If patients show alterations in speech or swallowing abilities they are…
AB Science recently announced that the European Medicines Agency (EMA) has accepted a conditional marketing authorization application for the tyrosine kinase inhibitor masitinib to treat amyotrophic lateral sclerosis (ALS). AB Science develops protein kinase inhibitors (PKIs), a class of targeted proteins that are key for signaling pathways within cells. It has been shown that blocking…
ALS patients are able to make self-determined decisions about their everyday life and their medical care, despite having moderate cognitive or behavioral impairment, suggests a study published in the scientific journal Neurology.
A report from scientists in the Netherlands indicates that patients with amyotrophic lateral sclerosis (ALS) who develop frontotemporal syndrome (FS), do not survive much longer when given a ventilation mask. In fact, 30 – 50% of patients with ALS and behavior/cognitive deficits due to FC do not respond to the breathing mask, called non-invasive…
Can Aromatics Help ALS? Essentials oils are the newest trend. But better known as aromatherapy, they’ve actually been around for centuries. There’s plenty of research behind this aromatic fad that helps to alleviate many health conditions. We’ve uncovered some ways essential oils can help with amyotrophic lateral sclerosis. The…
Several studies have shown that oligodendrocytes, cells that normally protect neurons, can also contribute to neuronal death in amyotrophic lateral sclerosis (ALS). Now, researchers demonstrate this toxic turn of events and show how these cells induce neuronal death. This finding may encourage new therapies for ALS to target the dysfunctional activity…
Neuraltus Pharmaceuticals has initiated the second Phase 2 clinical trial of NP001 for the treatment of amyotrophic lateral sclerosis (ALS), with the goal of confirming the clinical findings of the previous Phase 2 study in ALS patients with elevated levels of baseline inflammation. The study is currently recruiting…
By introducing a mutation in SOD1 — the protein believed to be responsible for a large part of amyotrophic lateral sclerosis (ALS) cases — researchers managed to prevent the protein from clumping in a way that kills neurons. The study, “A Phosphomimetic Mutation Stabilizes SOD1 and Rescues…
Cigarette smoking may speed progression of amyotrophic lateral sclerosis (ALS) and reduce survival in patients with the disease, according to a new collaborative study from Italian universities and research institutes. The study, “Influence of cigarette smoking on ALS outcome: a population-based study” was published in The Journal of Neurology…
Get regular updates to your inbox.
